KEI Letter

KEI letter to the NIH regarding need for better reporting on the utilization of licensed inventions and access in developing countries

Posted on by James Love

The PDF version of the letter has all tables and footnotes: KEI-NIH-28Aug2028 August 28, 2024 Abby Rives, JD Division Director Technology Transfer and Innovation Policy National Institutes for Health Vladimir Knezevic, MD Senior Advisor for Commercial Evaluation Technology Advancement Office… Continue Reading →

Letter to FDA on the Cost to the Public of the Pediatric Trial Exclusivity Extension

Posted on by KEI Staff

Today, Knowledge Ecology International (KEI) submitted a letter to the Commissioner of the Food and Drug Administration (FDA) regarding the mismatch between the cost to perform pediatric extension trials and the cost to the public of the six month extension… Continue Reading →